Claudia Langebrake

Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

Jan‐Henning Klusmann, Ursula Creutzig, Martin Zimmermann et al. · Blood · 2008 · 253 citations · Full text

Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling

Jean‐Pierre Bourquin, Aravind Subramanian, Claudia Langebrake et al. · Proceedings of the National Academy of Sciences · 2006 · 184 citations · Full text

Down Syndrome, Hematological Malignancy, Functional Genomics +15

Residual Disease Monitoring in Childhood Acute Myeloid Leukemia by Multiparameter Flow Cytometry: The MRD-AML-BFM Study Group

Claudia Langebrake, Ursula Creutzig, Michael Dworzak et al. · Journal of Clinical Oncology · 2006 · 148 citations · Full text

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

Susanne Viehmann, Andrea Teigler‐Schlegel, Jochen Bruch et al. · Leukemia · 2003 · 95 citations

Hematological Malignancy, Oncology, Aml1/eto Rearrangement +12

Immunophenotype of Down Syndrome Acute Myeloid Leukemia and Transient Myeloproliferative Disease Differs Significantly from Other Diseases with Morphologically Identical or Similar Blasts

Claudia Langebrake, U. Creutzig, Dirk Reinhardt · Klinische Pädiatrie · 2005 · 93 citations